Strategies to overcome hyperacute rejection of pig-to-human xenografts.
McKenzie
I F
IF
Austin Research Institute, Austin & Repatriation Medical Center, Heidelberg, Australia.
Osman
N
N
Cohney
S
S
Sandrin
M S
MS
D000208:Acute Disease; D000818:Animals; D030801:Animals, Genetically Modified; D000910:Antibodies, Heterophile / Q000302:isolation & purification; D000915:Antibody Affinity; D015478:Antigens, Heterophile / Q000276:immunology*; D003169:Complement Inactivator Proteins; D004187:Disaccharides / Q000276:immunology*; D004546:Elapid Venoms / Q000494:pharmacology; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D013552:Swine
D000910:Antibodies, Heterophile; D015478:Antigens, Heterophile; D003169:Complement Inactivator Proteins; D004187:Disaccharides; D004546:Elapid Venoms; C016310:cobra venom factor; C055075:galactosyl-(1-3)galactose